Clinical Trial

Artificial Intelligence-driven Tuberculosis Landscape Analysis & Stratification Research

Study acronym: TB-ATLAS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to establish and validate a comprehensive AI-driven clinical decision support system (AI-CDSS) in whole-chain management for pulmonary tuberculosis (TB) patients. The main question it aims to answer is: How is the predictive performance of this system in terms of multiple key links during TB diagnosis and treatment? Can real-world benefits be derived from this system? This AI framework supports clinicians in making smarter decisions, ultimately improving cure rates and ensuring that every patient receives the most effective, personalized care possible.
Trial Details
NCT Number NCT07611695
Lead Sponsor Huashan Hospital
Collaborators: The Hong Kong Polytechnic University
Conditions Pulmonary Tuberculosis, Tuberculosis (TB), Tuberculosis Active
Enrollment 31,600 participants
Start Date 2026-06-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-28